Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy

• Päätekijät: Jyoti Bhagatram Sharma (Tekijä), Manjunath Nookala Krishnamurthy (Tekijä), Ankita Awase (Tekijä), Amit Joshi (Tekijä), Vijay Patil (Tekijä), Vanita Noronha (Tekijä), Kumar Prabhash (Tekijä), Vikram Gota (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: SAGE Publishing, 2021-02-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Aim: Accurate causality assessment (CA) of adverse events (AEs) is important in clinical research and routine clinical practice. The Naranjo scale (NS) used for CA lacks specificity, leading to a high rate of false positive causal associations. NS is a simple scale for CA; however, its limitations h...